Literature DB >> 30242234

Plasma lipid profiling of tissue-specific insulin resistance in human obesity.

Birgitta W van der Kolk1, Nicole Vogelzangs2,3,4, Johan W E Jocken2, Armand Valsesia5, Thomas Hankemeier6, Arne Astrup7, Wim H M Saris2, Ilja C W Arts3,4, Marleen M J van Greevenbroek8, Ellen E Blaak2.   

Abstract

BACKGROUND/
OBJECTIVES: Obesity-associated insulin resistance (IR) may develop in multiple organs, representing different aetiologies towards cardiometabolic diseases. This study aimed to identify distinct plasma lipid profiles in overweight/obese individuals who show muscle-IR and/or liver-IR. SUBJECTS/
METHODS: Baseline data of the European multicenter DiOGenes project were used (n = 640; 401 women, nondiabetic BMI: 27-45 kg/m2). Muscle insulin sensitivity index (MISI) and hepatic insulin resistance index (HIRI) were derived from a 5-point oral glucose tolerance test. The 140 plasma lipids were quantified by liquid chromatography-mass spectrometry. Linear mixed models were used to evaluate associations between MISI, HIRI and plasma lipids.
RESULTS: MISI was comparable between sexes while HIRI and triacylglycerol (TAG) levels were lower in women than in men. MISI was associated with higher lysophosphatidylcholine (LPC) levels (standardized (std)β = 0.126; FDR-p = 0.032). Sex interactions were observed for associations between HIRI, TAG and diacylglycerol (DAG) lipid classes. In women, but not in men, HIRI was associated with higher levels of TAG (44 out of 55 species) and both DAG species (stdβ: 0.139-0.313; FDR-p < 0.05), a lower odd-chain/even-chain TAG ratio (stdβ = -0.182; FDR-p = 0.005) and a lower very-long-chain/long-chain TAG ratio (stdβ = -0.156; FDR-p = 0.037).
CONCLUSIONS: In overweight/obese individuals, muscle insulin sensitivity is associated with higher plasma LPC concentrations. Women have less hepatic IR and lower TAG than men. Nevertheless, hepatic IR is associated with higher plasma TAG and DAG concentrations and a lower abundance of odd-chain and very-long-chain TAG in women, but not in men. This suggests a more pronounced worsening of plasma lipid profile in women with the progression of hepatic IR.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30242234     DOI: 10.1038/s41366-018-0189-8

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  11 in total

Review 1.  An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.

Authors:  Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

2.  Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.

Authors:  Klev Diamanti; Marco Cavalli; Gang Pan; Maria J Pereira; Chanchal Kumar; Stanko Skrtic; Manfred Grabherr; Ulf Risérus; Jan W Eriksson; Jan Komorowski; Claes Wadelius
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

3.  The Relationship between Circulating Acetate and Human Insulin Resistance before and after Weight Loss in the DiOGenes Study.

Authors:  Manuel A González Hernández; Emanuel E Canfora; Kenneth Pasmans; A Astrup; W H M Saris; Ellen E Blaak
Journal:  Nutrients       Date:  2020-01-28       Impact factor: 5.717

4.  Current metabolic perspective on malnutrition in obesity: towards more subgroup-based nutritional approaches?

Authors:  Ellen E Blaak
Journal:  Proc Nutr Soc       Date:  2020-03-03       Impact factor: 6.297

Review 5.  Goals in Nutrition Science 2020-2025.

Authors:  Josep Bassaganya-Riera; Elliot M Berry; Ellen E Blaak; Barbara Burlingame; Johannes le Coutre; Willem van Eden; Ahmed El-Sohemy; J Bruce German; Dietrich Knorr; Christophe Lacroix; Maurizio Muscaritoli; David C Nieman; Michael Rychlik; Andrew Scholey; Mauro Serafini
Journal:  Front Nutr       Date:  2021-02-09

6.  The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile.

Authors:  Alana Aragón-Herrera; Manuel Otero-Santiago; Laura Anido-Varela; Sandra Moraña-Fernández; Manuel Campos-Toimil; Tomás García-Caballero; Luis Barral; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Oreste Gualillo; Isabel Moscoso; Ricardo Lage; José Ramón González-Juanatey; Sandra Feijóo-Bandín; Francisca Lago
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

7.  Sexual Dimorphism in Body Weight Loss, Improvements in Cardiometabolic Risk Factors and Maintenance of Beneficial Effects 6 Months after a Low-Calorie Diet: Results from the Randomized Controlled DiOGenes Trial.

Authors:  Inez Trouwborst; Gijs H Goossens; Arne Astrup; Wim H M Saris; Ellen E Blaak
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

Review 8.  Sample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity.

Authors:  Ivan Liakh; Tomasz Sledzinski; Lukasz Kaska; Paulina Mozolewska; Adriana Mika
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

9.  Obese Older Type 2 Diabetes Mellitus Patients with Muscle Insulin Resistance Benefit from an Enriched Protein Drink during Combined Lifestyle Intervention: The PROBE Study.

Authors:  Wilrike J Pasman; Robert G Memelink; Johan de Vogel-Van den Bosch; Mark P V Begieneman; Willem J van den Brink; Peter J M Weijs; Suzan Wopereis
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

10.  The PERSonalized Glucose Optimization Through Nutritional Intervention (PERSON) Study: Rationale, Design and Preliminary Screening Results.

Authors:  Anouk Gijbels; Inez Trouwborst; Kelly M Jardon; Gabby B Hul; Els Siebelink; Suzanne M Bowser; Dilemin Yildiz; Lisa Wanders; Balázs Erdos; Dick H J Thijssen; Edith J M Feskens; Gijs H Goossens; Lydia A Afman; Ellen E Blaak
Journal:  Front Nutr       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.